1. Home
  2. RANI vs APT Comparison

RANI vs APT Comparison

Compare RANI & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • APT
  • Stock Information
  • Founded
  • RANI 2012
  • APT 1983
  • Country
  • RANI United States
  • APT Canada
  • Employees
  • RANI 140
  • APT N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • APT
  • Sector
  • RANI Health Care
  • APT
  • Exchange
  • RANI Nasdaq
  • APT Nasdaq
  • Market Cap
  • RANI 55.3M
  • APT 61.6M
  • IPO Year
  • RANI 2021
  • APT 1995
  • Fundamental
  • Price
  • RANI $1.66
  • APT $5.62
  • Analyst Decision
  • RANI Strong Buy
  • APT
  • Analyst Count
  • RANI 6
  • APT 0
  • Target Price
  • RANI $11.33
  • APT N/A
  • AVG Volume (30 Days)
  • RANI 2.3M
  • APT 16.8K
  • Earning Date
  • RANI 03-19-2025
  • APT 03-12-2025
  • Dividend Yield
  • RANI N/A
  • APT N/A
  • EPS Growth
  • RANI N/A
  • APT 20.88
  • EPS
  • RANI N/A
  • APT 0.37
  • Revenue
  • RANI N/A
  • APT $59,288,000.00
  • Revenue This Year
  • RANI N/A
  • APT N/A
  • Revenue Next Year
  • RANI N/A
  • APT N/A
  • P/E Ratio
  • RANI N/A
  • APT $14.79
  • Revenue Growth
  • RANI N/A
  • APT 1.88
  • 52 Week Low
  • RANI $1.24
  • APT $4.64
  • 52 Week High
  • RANI $8.75
  • APT $6.92
  • Technical
  • Relative Strength Index (RSI)
  • RANI 54.80
  • APT 60.29
  • Support Level
  • RANI $1.59
  • APT $5.28
  • Resistance Level
  • RANI $1.90
  • APT $5.50
  • Average True Range (ATR)
  • RANI 0.15
  • APT 0.18
  • MACD
  • RANI 0.03
  • APT 0.02
  • Stochastic Oscillator
  • RANI 56.36
  • APT 37.63

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.

Share on Social Networks: